Century Therapeutics (IPSC) Capital Expenditures (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Capital Expenditures of $584000.0 for Q1 2026, up 22.95% year-over-year from $475000.0 in Q1 2025, and up 520.14% quarter-over-quarter from -$139000.0 in Q4 2025.
Century Therapeutics (IPSC) Capital Expenditures (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Capital Expenditures for 7 consecutive years, with $584000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures rose 22.95% year-over-year to $584000.0; the TTM figure through Mar 2026 stood at $957000.0 (down 57.64% YoY), while the FY2025 annual figure was $848000.0, up 450.65% from the prior year.
- Capital Expenditures rose to $584000.0 in Q1 2026 per IPSC's latest filing, from -$139000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $10.5 million in Q2 2022 and bottomed at -$21.7 million in Q4 2022.
- Historically, Capital Expenditures has averaged $1.2 million across 5 years, with a median of $584000.0 in 2026.
- On a YoY basis, Capital Expenditures climbed as much as 303.86% in 2022 and fell as far as 241.99% in 2022.
- Century Therapeutics' Capital Expenditures stood at -$21.7 million in 2022, then surged by 104.52% to $980000.0 in 2023, then plunged by 72.96% to $265000.0 in 2024, then plunged by 152.45% to -$139000.0 in 2025, then jumped by 520.14% to $584000.0 in 2026.
- Business Quant data shows IPSC's Capital Expenditures at $584000.0 in Q1 2026, -$139000.0 in Q4 2025, and $195000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 694,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 694,000.00 |
| Jun 30, 2026 | 694,000.00 |
| Mar 31, 2026 | 584,000.00 |
| Mar 31, 2026 | 584,000.00 |
| Dec 31, 2025 | -139,000.00 |
| Dec 31, 2025 | -139,000.00 |
| Sep 30, 2025 | 195,000.00 |
| Sep 30, 2025 | 195,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Jun 30, 2024 | 265,000.00 |
| Jun 30, 2024 | 265,000.00 |
| Mar 31, 2024 | 539,000.00 |
| Mar 31, 2024 | 539,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Dec 31, 2023 | 980,000.00 |
| Sep 30, 2023 | 3.27 Mn |
| Sep 30, 2023 | 3.27 Mn |